Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network.
Electroretinography (ERG) is an ophthalmic diagnostic method used to determine whether the retina is functioning normally. It is widely employed for diagnosing hereditary retinal diseases or assessing retinal function decline.
An international research team led by the University of Waterloo is developing technology to dissolve painful kidney stones in the urinary tract using tiny robots. The research is published in the journal Advanced Healthcare Materials.
MURRIETA, Calif., Aug. 12, 2025 /PRNewswire/ — Copan, a leader in microbiology laboratory and automation innovations, proudly announced the official launch of UriVerse™ during the Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo in Chicago, IL. UriVerse is a state-of-the-art, fully automated system that transforms the pre-analytical handling of urine specimens by automating key manual steps. UriVerse automates critical steps including de-capping, barcode labeling, aliquoting, and re-capping which helps laboratories reduce manual labor and minimize errors.
Interventional Systems and HICREN today announced approval for their joint venture’s surgical robot platform in China.
Agile Medical Technology today took to social media to introduce its Agibot Endoscopic Surgical System, a surgical robotic platform for endoscopic procedures.
Myra Vision announced today that it received FDA investigational device exemption (IDE) approval for its Calibreye system
Renata Medical announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Minima stent system.
Targeting cellular structures called nuclear speckles could be a completely new approach for treating proteinopathies—diseases driven by abnormal accumulation of misfolded proteins—such as Alzheimer’s, Parkinson’s and prion diseases.
A cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumors. The drug works by disarming a key defense mechanism that tumors use to protect themselves from treatment.